ATRX
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2023 Q3 | -0.83 | $0 | -$29,155 |
| 2023 Q2 | 0.07 | $0 | -$316,000 |
| 2023 Q1 | -0.29 | $0 | -$310,000 |
| 2022 Q4 | 0.51 | $0 | -$153,000 |
| 2022 Q3 | -0.57 | $0 | -$572,000 |
| 2022 Q2 | -0.27 | $0 | -$474,000 |
| 2022 Q1 | -0.51 | $0 | -$216,000 |
| 2021 Q4 | -0.13 | $0 | -$296,000 |